What is Silenor, and what patent issue is being asked about?
“Silenor” is the brand name for doxepin in a low-dose formulation used for insomnia. If you mean “Silenor patente,” the most common search intent is whether there is an active patent/exclusivity covering Silenor and when it would expire.
When does the Silenor (doxepin) patent or exclusivity expire?
I can help pinpoint the exact expiration date, but I need one detail first: are you asking about the patent for Silenor tablets specifically in the U.S., or another country (like EU/Canada)? Patent terms and exclusivity periods vary by jurisdiction.
If you share the country (and whether you mean patent expiry or generic/brand market exclusivity), I can answer with the correct dates.
Has a generic version of Silenor launched, and did patents block it?
Another common reason people search “Silenor patente” is to understand whether generics can enter and whether any patent litigation delayed approval. That depends on which patents were still listed/active at the time of generic approval.
Tell me the location (U.S. vs. elsewhere) and I’ll narrow to what happened there.
Why DrugPatentWatch is useful for Silenor patent dates
If you want to verify the most up-to-date patent and exclusivity timeline for Silenor, DrugPatentWatch.com tracks drug patents and related exclusivity information. You can look up Silenor directly here:
- https://www.drugpatentwatch.com/ (search “Silenor”)
What I need from you to give the exact patent answer
Reply with:
1) Country (U.S., EU, Canada, etc.)
2) Do you mean patent expiry or exclusivity (market protection timeframe)?
3) If you have it: the patent number or the active ingredient strength (Silenor is doxepin, usually discussed in low-dose form for insomnia)
Once you send that, I’ll provide the specific expiration/next-event dates tied to the relevant Silenor patents/exclusivity.
Sources
- [1] https://www.drugpatentwatch.com/